Zhang Y Y, Wu P J, Zhang Q
Zhonghua Nei Ke Za Zhi. 1989 Jun;28(6):340-2, 381.
The penetration of Cefuroxime (CXM), Ceftazidime (CTZ), Cefotaxime (CTX), Ceftizoxime (CZX), and Ceftriaxone (CTRX) across the blood-brain barrier was studied in 119 patients with or without meningitis after an intravenous injection of 2 grams. Cephalosporins were undetectable or their concentrations very low in the cerebrospinal fluid (CSF), when there was no inflammation in the meninges. On the contrary, the mean CSF concentrations of cephalosporins were 2.21-5.36 micrograms/ml and the CSF/serum ratios 3.73-31.80% in acute stage of purulent meningitis. The CSF levels of all the five cephalosporins were much higher than the mean MICs of the common pathogens of bacterial meningitis as well as that of Enterobacteriaceae. It is thus shown that these five new cephalosporins are useful for treatment of meningitis including those caused by gram-negative bacilli.
对119例有或没有脑膜炎的患者静脉注射2克头孢呋辛(CXM)、头孢他啶(CTZ)、头孢噻肟(CTX)、头孢唑肟(CZX)和头孢曲松(CTRX)后,研究了它们对血脑屏障的穿透情况。当脑膜无炎症时,脑脊液(CSF)中检测不到头孢菌素或其浓度非常低。相反,在化脓性脑膜炎急性期,头孢菌素的平均脑脊液浓度为2.21 - 5.36微克/毫升,脑脊液/血清比值为3.73 - 31.80%。所有五种头孢菌素的脑脊液水平均远高于细菌性脑膜炎常见病原体以及肠杆菌科细菌的平均最低抑菌浓度(MIC)。因此表明,这五种新型头孢菌素可用于治疗脑膜炎,包括由革兰氏阴性杆菌引起的脑膜炎。